Met Life Investment Management, LLC Pacira Bio Sciences, Inc. Transaction History

Met Life Investment Management, LLC

$16.5 Billion
Q2 2025

A detailed history of Met Life Investment Management, LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 27,547 shares of PCRX stock, worth $634,131. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,547

Previous 27,547 -0.0%

Holding current value

$634,131

Previous $684,000 3.8%

% of portfolio

0.0%

Previous 0.0%

37 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$18.33 - $27.25 $6,158 - $9,156	-336 Reduced 1.21%	27,547 $684,000
Q4 2024 Feb 13, 2025	BUY	$15.3 - $20.33 $22,506 - $29,905	1,471 Added 5.57%	27,883 $525,000
Q2 2024 Aug 13, 2024	BUY	$25.5 - $31.51 $61,761 - $76,317	2,422 Added 10.1%	26,412 $755,000
Q1 2024 May 14, 2024	BUY	$27.7 - $35.48 $664,523 - $851,165	23,990 New	23,990 $700,000
Q3 2023 May 09, 2024	BUY	$30.68 - $40.09 $9,786 - $12,788	319 Added 1.35%	23,990 $736,000
Q2 2023 Apr 29, 2024	BUY	$36.12 - $47.5 $866,518 - $1.14 Million	23,990 New	23,990 $961,000
Q2 2023 Aug 10, 2023	BUY	$36.12 - $47.5 $11,522 - $15,152	319 Added 1.35%	23,990 $961,000
Q1 2023 May 09, 2024	BUY	$35.53 - $43.38 $841,030 - $1.03 Million	23,671 New	23,671 $966 Million
Q1 2022 May 10, 2024	BUY	$60.03 - $76.49 $1.42 Million - $1.81 Million	23,671 New	23,671 $1.81 Million
Q1 2022 Mar 22, 2023	BUY	$60.03 - $76.49 $505,752 - $644,428	8,425 Added 55.26%	23,671 $1.81 Million
Q1 2022 May 12, 2022	BUY	$60.03 - $76.49 $505,752 - $644,428	8,425 Added 55.26%	23,671 $1.81 Million
Q4 2021 Jun 21, 2023	SELL	$47.97 - $62.21 $404,147 - $524,119	-8,425 Reduced 35.59%	15,246 $917,000
Q3 2021 May 17, 2024	SELL	$54.64 - $61.3 $82,506 - $92,563	-1,510 Reduced 9.01%	15,246 $853,000
Q3 2021 Jun 21, 2023	SELL	$54.64 - $61.3 $460,342 - $516,452	-8,425 Reduced 35.59%	15,246 $853,000
Q3 2021 Mar 22, 2023	SELL	$54.64 - $61.3 $82,506 - $92,563	-1,510 Reduced 9.01%	15,246 $853,000
Q3 2021 Nov 15, 2021	SELL	$54.64 - $61.3 $82,506 - $92,563	-1,510 Reduced 9.01%	15,246 $854,000
Q2 2021 Jun 21, 2023	SELL	$59.18 - $69.99 $409,229 - $483,980	-6,915 Reduced 29.21%	16,756 $1.02 Million
Q1 2021 May 17, 2024	SELL	$59.31 - $78.82 $429,048 - $570,183	-7,234 Reduced 30.15%	16,756 $1.17 Million
Q1 2021 Jun 26, 2023	SELL	$59.31 - $78.82 $410,128 - $545,040	-6,915 Reduced 29.21%	16,756 $1.17 Billion
Q1 2021 Mar 22, 2023	SELL	$59.31 - $78.82 $103,851 - $138,013	-1,751 Reduced 9.46%	16,756 $1.17 Million
Q1 2021 May 14, 2021	SELL	$59.31 - $78.82 $103,851 - $138,013	-1,751 Reduced 9.46%	16,756 $1.17 Million
Q4 2020 Jun 22, 2023	SELL	$50.47 - $66.26 $260,627 - $342,166	-5,164 Reduced 21.82%	18,507 $1.11 Million
Q3 2020 Jun 26, 2023	SELL	$51.97 - $63.0 $268,373 - $325,332	-5,164 Reduced 21.82%	18,507 $1.11 Million
Q2 2020 May 24, 2024	SELL	$30.8 - $52.47 $168,876 - $287,693	-5,483 Reduced 22.86%	18,507 $971 Million
Q2 2020 Jun 26, 2023	SELL	$30.8 - $52.47 $159,051 - $270,955	-5,164 Reduced 21.82%	18,507 $971,000
Q1 2020 Jul 12, 2023	SELL	$28.4 - $50.7 $146,657 - $261,814	-5,164 Reduced 21.82%	18,507 $620,000
Q4 2019 Jul 12, 2023	SELL	$36.31 - $46.83 $187,504 - $241,830	-5,164 Reduced 21.82%	18,507 $838,000
Q3 2019 Jul 12, 2023	SELL	$35.66 - $44.99 $184,148 - $232,328	-5,164 Reduced 21.82%	18,507 $704,000
Q2 2019 Jul 12, 2023	SELL	$36.57 - $47.97 $188,847 - $247,717	-5,164 Reduced 21.82%	18,507 $804,000
Q1 2019 Jul 13, 2023	SELL	$36.47 - $42.17 $188,331 - $217,765	-5,164 Reduced 21.82%	18,507 $704,000
Q4 2018 Jul 13, 2023	SELL	$41.31 - $52.16 $213,324 - $269,354	-5,164 Reduced 21.82%	18,507 $796,000
Q4 2018 Mar 22, 2023	SELL	$41.31 - $52.16 $423,097 - $534,222	-10,242 Reduced 35.63%	18,507 $796,000
Q4 2018 Feb 14, 2019	SELL	$41.31 - $52.16 $423,097 - $534,222	-10,242 Reduced 35.63%	18,507 $796,000
Q3 2018 Jul 13, 2023	SELL	$32.85 - $52.0 $169,637 - $268,528	-5,164 Reduced 21.82%	18,507 $909,000
Q3 2018 Mar 22, 2023	BUY	$32.85 - $52.0 $166,812 - $264,056	5,078 Added 21.45%	28,749 $1.41 Million
Q3 2018 Nov 14, 2018	BUY	$32.85 - $52.0 $336,449 - $532,584	10,242 Added 55.34%	28,749 $1.41 Million
Q4 2017 Feb 15, 2018	BUY	$31.85 - $46.95 $589,447 - $868,903	18,507	18,507 $845,000

Others Institutions Holding PCRX

# of Institutions

262

Shares Held

51M

Call Options Held

289K

Put Options Held

130K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.05B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account

Met Life Investment Management, LLC Pacira Bio Sciences, Inc. Transaction History